A follow-on phase 2 trial of QBECO in moderate to severe Crohn's disease patients

Trial Profile

A follow-on phase 2 trial of QBECO in moderate to severe Crohn's disease patients

Planning
Phase of Trial: Phase II

Latest Information Update: 03 Oct 2017

At a glance

  • Drugs QBECO (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Sponsors Qu Biologics
  • Most Recent Events

    • 03 Oct 2017 According to a Qu Biologics media release, the company expects to initiate this trial in the first quarter of 2018.
    • 19 Apr 2017 According to a Qu Biologics media release, this trial is expected to begin in late 2017 or early 2018.
    • 08 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top